Write a Comment
6 Comments
Yeah it would save money but also keep all the dumbasses on pills to make money still for Big Pharma.Then they will never ever want a cure which they don't anyhow.You think they want to loose all money? Hell NO..
Please tell me that we're not going back down the road of cost over health outcomes? The triple combination therapy regimen was designed on the basis that dual therapy was not effective enough. So in 1995, only 20 years ago, triple therapy was unveiled and we now have PLHIV to, in many cases, a ripe Old Age, previously unheard of. Is it now a case that too many of us are living too long and as a result the number have to be culled to suit the penny-pinchers/bean-counters in government?
New diagnosis of osteoporosis. With Viread being associated with bone density loss, I am hopeful that dropping Viread from my current Tivicay and Emtriva regimen will work.
I_dunno - The HIV drug Epivir (lamivudine) is also known as 3TC. However, lamivudine is not included among the antiretrovirals currently believed to cause lipodystrophy. Those include Retrovir (AZT, or zidovudine), Zerit (d4T, or stavudine) and Videx (ddI, or didanosine). Retrovir is a component of Combivir (zidovudine/lamivudine) and Trizivir (abacavir/zidovudine/lamivudine). It is the case that lamivudine is paired with a lipodystrophy-causing drug in Combivir.
Lamivudine is also known as 3TC, isn't it? Isn't this drug known to cause lipodystrophy? That's definitely a side-effect I'd pay to avoid!
Scott
Yeah, NO! It's cost over health - again. Pasco County HD in Florida used to refused to put patients on meds till there CD4 was below 200. Guess why? To save money. We have to make sure WE control our healthcare, not the doctors.
January 13, 2016